The Scleroderma Research Foundation (SRF) was established in 1987 by patient turned activist Sharon Monsky, when research on this potentially life threatening illness was nearly nonexistent. Since our founding, we have remained committed to the principle that the best way to help scleroderma patients is to fund the most promising research aimed at improved therapies and a cure.
The SRF is America’s largest nonprofit investor in scleroderma research and devotes a greater percentage of its annual budget to scleroderma research than any other nonprofit organization. Thanks in large part to the SRF and its many generous donors, research is progressing at a faster pace than ever before.